Vinay Prasad on the FDA-Industry Revolving Door and User Fees: warns against

What Prasad says

Dr. Vinay Prasad warns that industry funding of the FDA through user fees, combined with the revolving door of personnel between the agency and drug companies, creates conflicts of interest that bias approvals toward industry. The position comes from his pre-FDA Substack writings, covered by The Cancer Letter.

His stated reasoning

Prasad’s stated reasoning is that a regulator dependent on the industry it regulates for funding — and staffed by people who cycle in and out of that industry — cannot be neutral. The financial structure itself, he says, tilts decisions toward more approvals rather than better evidence.

This page chronicles a stated position of the person above. It is not medical advice and not the site's own conclusion.